Insight Molecular Diagnostics Inc. (IMDX) has a market capitalization of $91.8M and trades at $3.42. The 52-week range is 2.33-8.51.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.1, Earnings Per Share (EPS) of $-1.65, annual revenue of $4.06M.
The stock has a beta of 1.53, operates in the Healthcare sector.
